![]() |
|
|
Vol. 28, Issue 7, 833-844, July 2000
Bio-organic Section, Department of Organic Chemistry, Indian
Institute of Science, Bangalore, India (H.V.T., A.K.G., K.M.M.)
Metabolic disposition of
5,5-dimethyl-2-(1-methylethylidene)-cyclohexanone (I) was examined in
rats. Compound (I) was administered orally (250 mg/kg of body
weight/day) to rats for 5 days. The following urinary metabolites were
isolated and identified: 4,5,6,7-tetrahydro-3,6,6-trimethylbenzofuran (III), 3,3-dimethylcyclohexanone (VI),
5,5-dimethyl-3-hydroxy-2-(1-methylethylidene)-cyclohexanone (X),
5,5-dimethyl-2-(1-hydroxymethylethyl)-cyclohexanone (IX), 3-hydroxy-5-hydroxymethyl-5-methyl-2-(1-methylethylidene)-cyclohexanone (XI), 5,6-dihydro-3,6,6-trimethyl-2(4H)-benzofuranone
(VIII), and 5,5-dimethyl-3-hydroxy-2-(1-carboxy
ethylidene)-cyclohexanone (XIII). Incubation of compound (I) with
phenobarbital (PB)-induced rat liver microsomes in the presence
of NADPH resulted in the formation of a metabolite, tentatively
identified as a furanoterpene (III) based on proton magnetic
resonance, gas chromatography, and gas chromatography-mass
spectroscopy analyses. The formation of III was inhibited to a
significant extent by carbon monoxide, metyrapone, SKF 525-A, and
cytochrome c, suggesting the participation of PB-induced
microsomal cytochrome P-450 system in the conversion of I to III.
Compound I gave type I spectral change in the PB-induced liver
microsomes and the dissociation constant (Ks) for I was 38.5 µM. Intraperitoneal administration of a single dose (250 mg/kg)
of I to rats resulted in 26, 23, and 41% decreases in the levels of
cytochrome P-450, glucose-6-phosphatase, and aminopyrine N-demethylase, respectively, at the end of 24 h.
During this period, a 11-fold increase in serum glutamate pyruvate
transaminase level was also observed. However, a decrease in the level
of cytochrome P-450 and glucose-6-phosphatase, and an increase in serum
glutamate pyruvate transaminase values were comparatively more
pronounced when R-(+)-pulegone (250 mg/kg) or
CCl4 (0.6 ml/kg) was administered to rats. Pretreatment of
rats with PB potentiated the hepatotoxicity caused by I, whereas
pretreatment with 3-methylcholanthrene protected from it. This suggests
that PB-induced cytochrome P-450-catalyzed reactive metabolites may be
responsible for the toxic effects caused by I.
This article has been cited by other articles:
![]() |
H. V. Thulasiram, V. B. Bhat, and M. K. Madyastha Effect of Ring Size in R-(+)-Pulegone-Mediated Hepatotoxicity: Studies on the Metabolism of R-(+)-4-Methyl-2-(1-Methylethylidene)-Cyclopentanone and DL-Camphorone in Rats Drug Metab. Dispos., June 1, 2001; 29(6): 821 - 829. [Abstract] [Full Text] |
||||